Evidence map›Paper›PMID 31099708›Full record

ArticleMicrobial drug resistance (Larchmont, N.Y.)2019

Morphological and Biological Characteristics of

Ayami Sato, Tetsuo Yamaguchi, Masakaze Hamada, Daisuke Ono, Shiro Sonoda, Takashi Oshiro, Makoto Nagashima, Keisuke Kato, Shinichi Okazumi, Ryoji Katoh and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Microbial drug resistance (Larchmont, N.Y.), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. CRISPR-driven strategies to disrupt methicillin-resistantFrontiers in cellular and infection microbiology · 2026
    Review
  2. TheMicroorganisms · 2024
    Article
  3. Article
  4. Review
  5. Medicina (Kaunas, Lithuania) · 2022
    Article
  6. Article
  7. Article
  8. Increased Incidence and Plasma-Biofilm Formation Ability of SCCFrontiers in cellular and infection microbiology · 2021
    Article
  9. Prevalence and Therapies of Antibiotic-Resistance inFrontiers in cellular and infection microbiology · 2020
    Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Ayami Sato1 Department of Microbiology and Infectious Diseases, Faculty of Medicine, Toho University, Tokyo, Japan.
Tetsuo Yamaguchi1 Department of Microbiology and Infectious Diseases, Faculty of Medicine, Toho University, Tokyo, Japan.
Masakaze Hamada1 Department of Microbiology and Infectious Diseases, Faculty of Medicine, Toho University, Tokyo, Japan.
Daisuke Ono1 Department of Microbiology and Infectious Diseases, Faculty of Medicine, Toho University, Tokyo, Japan.
Shiro Sonoda1 Department of Microbiology and Infectious Diseases, Faculty of Medicine, Toho University, Tokyo, Japan.
Takashi Oshiro3 Department of Surgery, Sakura Medical Center, Toho University, Chiba, Japan.
Makoto Nagashima3 Department of Surgery, Sakura Medical Center, Toho University, Chiba, Japan.
Keisuke Kato5 Department of Pharmacology, Faculty of Pharmaceutical Sciences, Toho University, Chiba, Japan.
Shinichi Okazumi3 Department of Surgery, Sakura Medical Center, Toho University, Chiba, Japan.
Ryoji Katoh3 Department of Surgery, Sakura Medical Center, Toho University, Chiba, Japan.
Yoshikazu Ishii1 Department of Microbiology and Infectious Diseases, Faculty of Medicine, Toho University, Tokyo, Japan.
Kazuhiro Tateda1 Department of Microbiology and Infectious Diseases, Faculty of Medicine, Toho University, Tokyo, Japan.
Toho University · JPTokyo Medical and Dental University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Characteristics of

Indexed as

Drug Resistance, Multiple, BacterialAnti-Bacterial AgentsBiofilmsCulture Media, Serum-FreeDaptomycinHumansMethicillin-Resistant Staphylococcus aureusMicrobial Sensitivity TestsRheologyStaphylococcal InfectionsVancomycinAnti-Bacterial AgentsCulture Media, Serum-FreeDaptomycinVancomycinCA-MRSACOCRMMRSAplasma biofilm

Identifiers

PMID31099708
PMCPMC6555173
OpenAlexW2946764453

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.